Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
Clinical trial NCT04501939 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04501939
- Sponsor
- University of California, San Diego
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-06
- Primary completion
- 2026-07-22
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.